Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H21F3N2O |
Molecular Weight | 422.4422 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(O)C1=CC=CC=C1C2=CC=C3N=C(NC3=C2)\C=C\C4=CC=C(C=C4)C(F)(F)F
InChI
InChIKey=ORDHXXHTBUZRCN-NTEUORMPSA-N
InChI=1S/C25H21F3N2O/c1-24(2,31)20-6-4-3-5-19(20)17-10-13-21-22(15-17)30-23(29-21)14-9-16-7-11-18(12-8-16)25(26,27)28/h3-15,31H,1-2H3,(H,29,30)/b14-9+
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q8NER1 Gene ID: 7442.0 Gene Symbol: TRPV1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/25850459 |
4.6 nM [IC50] |
PubMed
Title | Date | PubMed |
---|---|---|
Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep). | 2015 May 14 |
|
A multiple-dose double-blind randomized study to evaluate the safety, pharmacokinetics, pharmacodynamics and analgesic efficacy of the TRPV1 antagonist JNJ-39439335 (mavatrep). | 2018 Apr 25 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
F197218T99
Created by
admin on Sat Dec 16 16:43:14 GMT 2023 , Edited by admin on Sat Dec 16 16:43:14 GMT 2023
|
PRIMARY | |||
|
17751090
Created by
admin on Sat Dec 16 16:43:14 GMT 2023 , Edited by admin on Sat Dec 16 16:43:14 GMT 2023
|
PRIMARY | |||
|
ZZ-122
Created by
admin on Sat Dec 16 16:43:14 GMT 2023 , Edited by admin on Sat Dec 16 16:43:14 GMT 2023
|
PRIMARY | |||
|
300000034276
Created by
admin on Sat Dec 16 16:43:14 GMT 2023 , Edited by admin on Sat Dec 16 16:43:14 GMT 2023
|
PRIMARY | |||
|
DTXSID90241905
Created by
admin on Sat Dec 16 16:43:14 GMT 2023 , Edited by admin on Sat Dec 16 16:43:14 GMT 2023
|
PRIMARY | |||
|
956274-94-5
Created by
admin on Sat Dec 16 16:43:14 GMT 2023 , Edited by admin on Sat Dec 16 16:43:14 GMT 2023
|
PRIMARY | |||
|
CHEMBL2364618
Created by
admin on Sat Dec 16 16:43:14 GMT 2023 , Edited by admin on Sat Dec 16 16:43:14 GMT 2023
|
PRIMARY | |||
|
m11672
Created by
admin on Sat Dec 16 16:43:14 GMT 2023 , Edited by admin on Sat Dec 16 16:43:14 GMT 2023
|
PRIMARY | |||
|
C170153
Created by
admin on Sat Dec 16 16:43:14 GMT 2023 , Edited by admin on Sat Dec 16 16:43:14 GMT 2023
|
PRIMARY | |||
|
9808
Created by
admin on Sat Dec 16 16:43:14 GMT 2023 , Edited by admin on Sat Dec 16 16:43:14 GMT 2023
|
PRIMARY | |||
|
DB12875
Created by
admin on Sat Dec 16 16:43:14 GMT 2023 , Edited by admin on Sat Dec 16 16:43:14 GMT 2023
|
PRIMARY | |||
|
Mavatrep
Created by
admin on Sat Dec 16 16:43:14 GMT 2023 , Edited by admin on Sat Dec 16 16:43:14 GMT 2023
|
PRIMARY |
ACTIVE MOIETY